Literature DB >> 28559424

C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.

Jeffrey S Smith1, Priya Alagesan1, Nimit K Desai1, Thomas F Pack1, Jiao-Hui Wu1, Asuka Inoue1, Neil J Freedman1, Sudarshan Rajagopal2.   

Abstract

Biased agonism, the ability of different ligands for the same receptor to selectively activate some signaling pathways while blocking others, is now an established paradigm for G protein-coupled receptor signaling. One group of receptors in which endogenous bias is critical is the chemokine system, consisting of over 50 ligands and 20 receptors that bind one another with significant promiscuity. We have previously demonstrated that ligands for the same receptor can cause biased signaling responses. The goal of this study was to identify mechanisms that could underlie biased signaling between different receptor splice variants. The C-X-C motif chemokine receptor 3 (CXCR3) has two splice variants, CXCR3A and CXCR3B, which differ by 51 amino acids at its N-terminus. Consistent with an earlier study, we found that C-X-C motif chemokine ligands 4, 9, 10, and 11 all activated G αi at CXCR3A, while at CXCR3B these ligands demonstrated no measurable G αi or G αs activity. β-arrestin (βarr) was recruited at a reduced level to CXCR3B relative to CXCR3A, which was also associated with differences in βarr2 conformation. βarr2 recruitment to CXCR3A was attenuated by both G protein receptor kinase (GRK) 2/3 and GRK5/6 knockdown, while only GRK2/3 knockdown blunted recruitment to CXCR3B. Extracellular regulated kinase 1/2 phosphorylation downstream from CXCR3A and CXCR3B was increased and decreased, respectively, by βarr1/2 knockout. The splice variants also differentially activated transcriptional reporters. These findings demonstrate that differential splicing of CXCR3 results in biased responses associated with distinct patterns of βarr conformation and recruitment. Differential splicing may serve as a common mechanism for generating biased signaling and provides insights into how chemokine receptor signaling can be modulated post-transcriptionally.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28559424      PMCID: PMC5508197          DOI: 10.1124/mol.117.108522

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  72 in total

1.  Isolation, crystallization, and primary amino acid sequence of human platelet factor 4.

Authors:  M Hermodson; G Schmer; K Kurachi
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

Review 2.  CXCR3 ligands in disease and therapy.

Authors:  Katrien Van Raemdonck; Philippe E Van den Steen; Sandra Liekens; Jo Van Damme; Sofie Struyf
Journal:  Cytokine Growth Factor Rev       Date:  2014-11-22       Impact factor: 7.638

3.  Phosphorylation of the platelet-derived growth factor receptor-beta and epidermal growth factor receptor by G protein-coupled receptor kinase-2. Mechanisms for selectivity of desensitization.

Authors:  Neil J Freedman; Luke K Kim; John P Murray; Sabrina T Exum; Leigh Brian; Jiao-Hui Wu; Karsten Peppel
Journal:  J Biol Chem       Date:  2002-10-14       Impact factor: 5.157

4.  Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor.

Authors:  Seungkirl Ahn; Jihee Kim; Carmen L Lucaveche; Mary C Reedy; Louis M Luttrell; Robert J Lefkowitz; Yehia Daaka
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

5.  beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.

Authors:  Diane Gesty-Palmer; Hesham El Shewy; Trudy A Kohout; Louis M Luttrell
Journal:  J Biol Chem       Date:  2005-07-15       Impact factor: 5.157

6.  G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors.

Authors:  Jiao-Hui Wu; Lisheng Zhang; Alexander C Fanaroff; Xinjiang Cai; Krishn C Sharma; Leigh Brian; Sabrina T Exum; Sudha K Shenoy; Karsten Peppel; Neil J Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

7.  Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.

Authors:  Elisa Alvarez-Curto; Asuka Inoue; Laura Jenkins; Sheikh Zahir Raihan; Rudi Prihandoko; Andrew B Tobin; Graeme Milligan
Journal:  J Biol Chem       Date:  2016-11-16       Impact factor: 5.157

8.  CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.

Authors:  Anja Mueller; Andrea Meiser; Ellen M McDonagh; James M Fox; Sarah J Petit; Georgina Xanthou; Timothy J Williams; James E Pease
Journal:  J Leukoc Biol       Date:  2008-01-03       Impact factor: 4.962

9.  Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.

Authors:  Jihee Kim; Seungkirl Ahn; Keshava Rajagopal; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2009-03-02       Impact factor: 5.157

10.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.

Authors:  D D Taub; A R Lloyd; K Conlon; J M Wang; J R Ortaldo; A Harada; K Matsushima; D J Kelvin; J J Oppenheim
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  23 in total

1.  Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation.

Authors:  Jeffrey S Smith; Lowell T Nicholson; Jutamas Suwanpradid; Rachel A Glenn; Nicole M Knape; Priya Alagesan; Jaimee N Gundry; Thomas S Wehrman; Amber Reck Atwater; Michael D Gunn; Amanda S MacLeod; Sudarshan Rajagopal
Journal:  Sci Signal       Date:  2018-11-06       Impact factor: 8.192

2.  Isoforms of GPCR proteins combine for diverse signalling.

Authors:  Joshua C Snyder; Sudarshan Rajagopal
Journal:  Nature       Date:  2020-11       Impact factor: 49.962

Review 3.  Biased signalling: from simple switches to allosteric microprocessors.

Authors:  Jeffrey S Smith; Robert J Lefkowitz; Sudarshan Rajagopal
Journal:  Nat Rev Drug Discov       Date:  2018-01-05       Impact factor: 84.694

Review 4.  How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.

Authors:  Krishna Rajarathnam; Michael Schnoor; Ricardo M Richardson; Sudarshan Rajagopal
Journal:  Cell Signal       Date:  2018-11-19       Impact factor: 4.315

Review 5.  The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.

Authors:  Andreas Bikfalvi; Clotilde Billottet
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

6.  Tandem Mass Tag Labeling Facilitates Reversed-Phase Liquid Chromatography-Mass Spectrometry Analysis of Hydrophilic Phosphopeptides.

Authors:  Chia-Feng Tsai; Jeffrey S Smith; Krzysztof Krajewski; Rui Zhao; Ahmed M Moghieb; Carrie D Nicora; Xinyu Xiong; Ronald J Moore; Tao Liu; Richard D Smith; Jon M Jacobs; Sudarshan Rajagopal; Tujin Shi
Journal:  Anal Chem       Date:  2019-08-28       Impact factor: 6.986

Review 7.  Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review.

Authors:  Devi Satarkar; Chinmoy Patra
Journal:  Front Cell Dev Biol       Date:  2022-06-20

8.  Mycobacterial growth inhibition is associated with trained innate immunity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Sandra M Arend; Corine Prins; Fredrik Oftung; Gro Ellen Korsvold; Sandra V Kik; Rob Jw Arts; Reinout van Crevel; Mihai G Netea; Tom Hm Ottenhoff
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

9.  Noncanonical scaffolding of Gαi and β-arrestin by G protein-coupled receptors.

Authors:  Jeffrey S Smith; Thomas F Pack; Asuka Inoue; Claudia Lee; Kevin Zheng; Issac Choi; Dylan S Eiger; Anmol Warman; Xinyu Xiong; Zhiyuan Ma; Gayathri Viswanathan; Ian M Levitan; Lauren K Rochelle; Dean P Staus; Joshua C Snyder; Alem W Kahsai; Marc G Caron; Sudarshan Rajagopal
Journal:  Science       Date:  2021-01-21       Impact factor: 63.714

Review 10.  New insights in chemokine signaling.

Authors:  Daniel F Legler; Marcus Thelen
Journal:  F1000Res       Date:  2018-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.